Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 3,460 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolic Effects Clear all

Conditions: Obesity
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 2,458 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2016
U.S. locations: 9
States / cities: New York, New York • Greenville, North Carolina • Fargo, North Dakota + 3 more

Conditions: Lactational Amenorrhea, Body Weight Changes, Bone Loss
Interventions: Exercise and dietary; Other
Lead sponsor: North Carolina Agriculture & Technical State University; Other
Eligibility: 25 Years to 40 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: HIV Infections, HIV Wasting Syndrome
Interventions: Nandrolone decanoate; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2003
U.S. locations: 20
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 14 more

Conditions: Obesity
Interventions: Metabolic & Bariatric Surgery; Procedure
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Obesity, Abdominal
Interventions: Resistance Training, Aerobic Training; Other
Lead sponsor: Southern Illinois University Edwardsville; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Edwardsville, Illinois

Conditions: Postmenopausal
Interventions: Exercise, No exercise; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Type 1 Diabetes
Interventions: Low-calorie sweetener restriction; Behavioral
Lead sponsor: Allison Sylvetsky (Meni); Other
Eligibility: 6 Years to 12 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obesity or Overweight, Diabetes Mellitus, Type 2
Interventions: Lenbelintide, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 56
States / cities: Fairhope, Alabama • Huntsville, Alabama • Mobile, Alabama + 49 more

Conditions: Coronary Artery Disease, Coronary Heart Disease, Dyslipidemia
Interventions: ABT-335, Placebo, Atorvastatin; Drug · Other
Lead sponsor: AbbVie (prior sponsor, Abbott); Industry
Eligibility: 45 Years and older
Enrollment: 682 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 124
States / cities: Chandler, Arizona • Gilbert, Arizona • Mesa, Arizona + 67 more

Conditions: Dialysis, Cardiovascular Disease, Atherosclerosis, Inflammation, Hyperphosphatemia
Interventions: Sevelamer Carbonate (Renvela); Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 10
States / cities: Boston, Massachusetts • Framingham, Massachusetts • Marlborough, Massachusetts + 5 more

Conditions: Type2 Diabetes, Insulin Sensitivity
Interventions: Empagliflozin 25 MG; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Diabetes, Inactivity
Interventions: NuStep fitness apparatus; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders, Endocrine System Diseases, Autoimmune Diseases
Interventions: FlorenceM, Medtronic insulin pump 640G; Device
Lead sponsor: University of Cambridge; Other
Eligibility: 6 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Aurora, Colorado • Minneapolis, Minnesota

Conditions: Type 2 Diabetes Mellitus, Heart Failure
Interventions: Saxagliptin, Sitagliptin, Placebo to match saxagliptin, Placebo to match sitagliptin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 11
States / cities: Torrance, California • Upland, California • Miami, Florida + 7 more

Conditions: Diabetes Mellitus, Type 2
Interventions: rosiglitazone, placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Aging Well, Aging
Interventions: Sodium lactate infusion, Exercise-induced hyperlactatemia; Biological · Other
Lead sponsor: Northern Arizona University; Other
Eligibility: 20 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Flagstaff, Arizona

Conditions: Impaired Glucose Tolerance, Prediabetes
Interventions: CGM; Device
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 10 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Insulin Sensitivity
Interventions: Blueberry Powder, Placebo; Dietary Supplement
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 20 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Body Weight Change, Schizophrenia, Schizoaffective Disorder, Psychotic Disorder
Interventions: Aripiprazole; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 23
States / cities: Little Rock, Arkansas • Anaheim, California • Cerritos, California + 20 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Semaglutide, Placebo (semaglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 72
States / cities: Phoenix, Arizona • Tucson, Arizona • Coronado, California + 54 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Oral semaglutide, Sitagliptin; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 43,650 participants
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vitamin D Deficiency
Interventions: 1,000 IU vitamin D2, placebo capsule, mushrooms, UVB-treated mushrooms, 400 IU vitamin D2, UVB-treated mushrooms, 1,000 IU vitamin D2; Dietary Supplement · Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 20 Years to 59 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Davis, California

Conditions: Low Energy, Dehydration, Bloating, Women's Wellness
Interventions: Daily Love Electrolytes; Dietary Supplement
Lead sponsor: Love Wellness; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Visceral Obesity, Insulin Resistance
Interventions: Water-only fasting; Other
Lead sponsor: TrueNorth Health Foundation; Other
Eligibility: 40 Years to 70 Years
Enrollment: 48 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Santa Rosa, California

Search by objective public record fields.

Long-term Effects of Bariatric Surgery

Effects of Exercise and Yogurt on Bone Mineral Density and Immunological Factors in Human Milk: The MEEMA Study

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology

Effects of Aerobic and Resistance Training on Abdominal Fat Loss

Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women

Effects of Low-calorie Sweetened Beverage Restriction in Youth With Type 1 Diabetes

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan

Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes

Analysis of the NuStep as an Introductory Fitness Regimen

Home Testing of Day and Night Closed Loop With Pump Suspend Feature

Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure

Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride

The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging

CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance

The Effect of Blueberries on Enhancing Insulin Sensitivity in Humans: A Pilot Study

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Emulation of the SOUL Diabetes Trial in Healthcare Claims

Effect of Consumption of Post-harvest UV-B Treated Mushrooms on Vitamin D Status of Healthy Adults

A Clinical Trial to Evaluate the Effects of an Electrolyte Supplement on Women's Wellness

The Effects of Water-only Fasting and Refeeding on Body Composition